A Study of Fosfomycin Trometamol and Trimethoprim in Urinary Infections in General Practice

2015 ◽  
pp. 191-196
Author(s):  
R. C. O�Dowd
1987 ◽  
Vol 25 (18) ◽  
pp. 69-72

Ciprofloxacin (Ciproxin - Bayer) is the first of the new fluoroquinolone drugs to be introduced in Britain. Others, pefloxacin, norfloxacin, and ofloxacin are undergoing clinical trials. All are 60 times more active than nalidixic acid, the best known early quinolone, and reach bactericidal concentrations at many sites against a much wider range of organisms. Ciprofloxacin can be given by mouth or intravenously. It is strongly promoted for use in respiratory and urinary infections in general practice and in hospital. Several sponsored publications report on it.1–4


The Lancet ◽  
1976 ◽  
Vol 307 (7970) ◽  
pp. 1184-1185 ◽  
Author(s):  
John Crump ◽  
Linda Pead ◽  
Rosalind Maskell

The Lancet ◽  
1965 ◽  
Vol 285 (7386) ◽  
pp. 653
Author(s):  
J STANSFELD

1973 ◽  
Vol 11 (24) ◽  
pp. 93-94

We recently reviewed the use of long-term low-dose chemotherapy to prevent recurrent urinary infections1 and briefly mentioned instructions which could be given to patients to supplement the drug treatment. The effectiveness of such measures is not readily tested by conventional trials, but many clinicians consider that they can help patients with bacterial cystitis and are also worth trying in those women with frequent symptoms of cystitis but without bacteriuria. Only about half the women presenting with urinary symptoms in general practice have infected urine. Recurrent urinary symptoms may be due to the urethral syndrome, gynaecological disorders or even psychiatric disturbances.


Sign in / Sign up

Export Citation Format

Share Document